Skip to main content
OpenTrials

Clinical trial condition

Lymphadenopathy

Explore clinical trials studying Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Lymphadenopathy trial results

Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

NCT00049400

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +41 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States
View all 23 locations
View Trial Details
Completed

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00352443

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +43 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States
View Trial Details
Completed

RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

NCT01198665

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma, Cutaneous T Cell Lymphoma, +15 more
Locations
  • National Cancer Center Goyang-si, Kyoungki-do, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
  • Korea Cancer Center Hospital Seoul, South Korea
View Trial Details

Related conditions